Abstract Submission

Back

  • Abstract Submission opens:
    May 29, 2020
  • Submission deadline:
    November 18, 2020 (23:59 CET)
  • Notification of acceptance:
    by January 4, 2021

How to submit your abstract (submission opens on May 29, 2020): Submissions have to be made via our online platform, available via this page. After your submission has been completed, you will receive a confirmation message within two business days. If this email does not appear, please be sure to check your spam / junk mail folder. If you submit your abstract on the day of the deadline (November 18) and do not receive confirmation within 48 hours, please email: abstractswcn@theisn.org to be sure your abstract has been received.

Abstracts should focus on all aspects of nephrology, the treatment of renal disease or the scientific background relating to the study of the kidney.

NEW for WCN'21:

Due to the new reality resulting from the COVID-19 pandemic with many meetings being cancelled or made virtual, we will allow abstracts that were submitted for other meetings in 2020. Please note:

  • It is MANDATORY for abstract authors to declare this at the end of each such abstract, clearly stating the name of the original meeting in the following way: This abstract was also submitted for XY congress.
  • By submitting the abstract to WCN 2021, abstract authors declare that re-submitting the abstract is permitted by the organizers of the original meeting.

Check out the abstract categories below:

Categories and topics

  1. Acute kidney injury clinical, drugs, AKI-CKD continuum
  2. Acute kidney injury – mechanisms, experimental models and biomarkers
  3. Acid-base and electrolyte abnormalities in kidney disease
  4. Experimental models- glomerulonephritis
  5. Clinical glomerulonephritis
  6. Tropical kidney diseases (viral nephropathies, TB, Schistosomiasis)
  7. Kidney in pregnancy and post-partum
  8. Other AKI

 

  1. Chronic kidney disease diagnosis, classification and progression
  2. Chronic kidney disease complications (CVD, hypertension, anemia, BMD, nutrition, infection)
  3. Epidemiology, outcomes and health service research related to CKD or its complications
  4. Diabetic kidney disease, drugs and treatments
  5. Chronic kidney disease, experimental models, biomarkers, precision medicine
  6. Vascular biology and endothelial function
  7. Physiology of tubular function and tubulointerstitial kidney disease
  8. Essential hypertension & renovascular kidney disease
  9. Special challenges in the burden and management of CKD in developing countries
  10. Genetics and epigenetics (including common and rare genetic diseases)
  11. Inflammation, fibrosis, matrix biology and oxidative stress
  12. Urologic disorders –stones, nephrocalcinosis
  13. Nephrotic syndrome
  14. Other CKD
  1. Epidemiology, outcomes and health services research in dialysis
  2. Haemodialysis, haemodiafiltration and vascular access
  3. Peritoneal dialysis
  4. Bioethics, supportive/palliative care and quality of life in ESRD
  5. Kidney transplantation and transplant immunology
  6. Other ESKD
  1. Training
  2. Social media
  3. Curriculum
  4. Online learning

Further instructions to complete your online application:

  • Character count: You are allowed to use 3,400 characters. Spaces are included in the character count (tables and graphs do not contribute to the character count if inserted as image).
  • Abstracts are structured: Introduction, methods, results, conclusion. Tables, graphs and pictures may be included (tables and graphs do not contribute to the character count if inserted as an image).
  • Pictures and images must be in JPEG and/or PNG format (uploaded image cannot exceed the dimensions of 640w x 480h in pixels and 1,5 Megabytes).
  • Case reports that present novel hypotheses, pathologies, treatments or ethical issues are welcome. However, they are likely to be selected only if such novelty can be highlighted.
  • We do not accept encore abstracts.
  • Number of abstract co-authors: Maximum number of abstract co-authors possible to list in your abstract is 15.
  • Please check your abstract carefully for typographical errors, misspellings, poor hyphenation, etc. They will be glaringly apparent in the published abstract. Please check that your abstract title is correct.

Please be aware:
We are a paperless congress. Accepted abstracts will be published electronically in the searchable databases of WCN’21 and Kidney International Reports (an official journal of the International Society of Nephrology). No printed abstract book will be produced.

It is mandatory for the presenting author to register to the Congress by January 27, 2021 in order to have the abstract published as described above and for poster/oral presentation. If you have submitted an abstract for the congress, it is mandatory to use the same congress profile (login identity) for your registration. Handling fee

  • A 40 USD non-refundable handling fee will be charged per abstract that is submitted. The handling fee must be paid by credit card (American Express, MasterCard, or Visa) at the time of submitting the abstract. Payment by bank transfer is not possible. Abstract handling fees are waived for submitters from low-income countries as defined by the World Bank (please scroll down for the full list of low-income countries). Abstract handling fees are waived only from submitters from these countries. Handling fee for Late Breaking Clinical Trials abstracts is 100 USD and is not waived for submitters from from low-income countries.
  • If the presenting author is unable to present the abstract, another co-author can take his/her place as long as he/she is duly registered to the congress. A letter from the presenting author informing about the change is requested and must be sent to the congress secretariat, email: abstractswcn@theisn.org, no later than January 27, 2021. If selected abstract presenters fail to register by January 27, 2021, no abstract will be published. There will also be no poster/oral presentation at the congress.
  • Once you have submitted your abstract, you cannot withdraw or change your abstract.
  • All copyrights are assigned to ISN.
  • Each abstract will be considered for a poster or oral presentation session. However, only limited slots are available for oral presentations during WCN’21.
  • ISN Young Nephrologists Awards - The ISN is offering presenting authors under the age of 40 the opportunity to apply for two (2) Young Nephrologists Awards. These awards will cover travel and accommodation contribution to attend the congress. Each winner will have 10 mins oral abstract presentation during a session at the congress. Application for the award is possible only during the online abstract submission process.

Low Income Countries:

Afghanistan Guinea-Bissau Sierra Leone
Benin Haiti Somalia
Burkina Faso Korea, Dem. People's Rep. South Sudan
Burundi Liberia Syrian Arab Republic
Central African Republic Madagascar Tajikistan
Chad Malawi Tanzania
Congo, Dem. Rep Mali Togo
Eritrea Mozambique Uganda
Ethiopia Nepal Yemen, Rep.
Gambia, The Niger  
Guinea Rwanda  

Organ trafficking and tourism ethics compliance
We believe that scientific studies and clinical activities must be performed in keeping with the ethical principles delineated in the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.

By submitting an abstract for WCN 2021, you state that you have not violated any aspect of the following:

Late Breaking Abstracts
A call for Late Breaking Clinical Trial Abstracts will open May 29, 2020 and will close on January 27, 2021. A 100 USD non-refundable handling fee will be charged per abstract that is submitted in this category. The fee is not waived for submitters from low-income countries. Late breaking abstracts will be considered for potential oral presentation in one of the sessions during the WCN’21. Late breaking abstracts should follow the standard ISN structure: Introduction, Methods, Results and Conclusions.

Late-breaking abstracts describe the latest advances and trial data & results that will change daily clinical practice and have not been previously published nor presented. They should highlight novel and practice-changing studies. The call for Late breaking abstracts is NOT an extension of the general submission deadline (November 18, 2020).

The focus of Late breaking abstracts is placed on capturing abstracts with ground-breaking and unique data that would not otherwise have been presented at the World Congress of Nephrology 2021. If you have data available for submission only after the regular abstract deadline, the Scientific Program Working Group would be interested to receive your submission and consider it for presentation.

FOR SUBMITTERS: In order to be considered for presentation, Late breaking abstract submitters are required to submit a ‘place holder’ abstract during the regular submission period (deadline November 18, 2020) . To submit your abstract – please log in to your congress profile and hit the button LATE BREAKING CLINICAL TRIAL ABSTRACT(S).

To update your abstract – please send a letter of intention to the Congress secretariat abstractswcn@theisn.org no later than January 20, 2021. We will then re-open the abstract submission portal for the respective author to make updates until January 27, 2021.

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact